Christina Bennett, MS, Author at Gastroenterology Advisor

A recent article is only the latest in a series of studies drawing attention to the importance of di

RAPIDO Trial Supports New Standard of Care for Advanced Rectal Cancer

By

December 29, 2020

Short-course radiotherapy followed by chemotherapy and total mesorectal excision improved outcomes for patients with high-risk locally advanced rectal cancer.

Researchers are making progress in the search for biomarkers that can help identify which patients a

General Gastroenterology

Biomarkers Aren’t Consistently Used to Select Participants for Immunotherapy Trials

By

Christina Bennett, MS

November 24, 2020

Only a minority of clinical trials evaluating immunotherapeutic agents in 2019 used a biomarker to select patients for enrollment, a study found.

Comprehensive genomic profiling shows promise in advanced esophageal squamous cell carcinomas and ad

Esophagus

Genomic Instability Predicts Risk of Progression for Barrett Esophagus

By

Christina Bennett, MS

September 21, 2020

Genomic copy number instability predicted the risk of disease progression among patients with Barrett esophagus years beforehand.

The presence of CHEK2 or PALB2 variants in Hispanic women is enough to warrant the addition of an annual breast MRI, said study authors.

Colorectal neoplasia

Hyperthyroidism Therapies Not Linked to Solid Cancer Mortality

By

Christina Bennett, MS

September 4, 2020

A team of investigators conducted a multicenter cohort study to determine if a relationship existed between treatment for hyperthyroidism and risk of death from solid cancer.

Even though older adults were prescribed second-line therapies less frequently than younger adults, patients had similar overall survival outcomes across age subgroups.

General Gastroenterology

Communication Style for Discussing Genetic Testing With Patients

By

Christina Bennett, MS

July 22, 2020

The Consistent Testing Terminology Working Group selected plain language terminology that can be used when communicating with cancer patients about genetic testing.

Other bowel disorders

Bowel Procedure During Ovarian Surgery Linked to Higher Odds of Surgical Infection

By

Christina Bennett, MS

July 16, 2020

The odds of developing a surgical infection after cytoreductive surgery for ovarian cancer more than doubled in women who had bowel resection or repair.

Lymph node with metastatic colonic adenocarcinoma

Colorectal neoplasia

Adding Cetuximab to Chemotherapy Shortens Survival by 2 Years in Advanced CRC

By

Christina Bennett, MS

February 18, 2020

Adding cetuximab to chemotherapy led to worse outcomes for patients with resectable liver metastases caused by colorectal cancer, updated data from the New EPOC trial showed.

Colonic stenting can be used as a temporizing measure to help bridge the patient to surgery for opti

Colorectal neoplasia

Evidence Supports the Potential Use of KRAS(G12C) Inhibitor, Maybe Even in Combination

By

Christina Bennett, MS

November 29, 2019

Preclinical and emerging clinical evidence support the possible use of AMG 510 as a single-agent KRAS (G12C) inhibitor, but preclinical evidence may also support the agent in combination.